APA (7th ed.) Citation

JD, B., N, V., L, R., PA, V., BD, C., JA, C., . . . GK, F. (2019). A novel in situ multiplex immunofluorescence panel for the assessment of tumor immunopathology and response to virotherapy in pediatric glioblastoma reveals a role for checkpoint protein inhibition. Oncoimmunology, 8(12), e1678921. https://doi.org/10.1080/2162402X.2019.1678921

Chicago Style (17th ed.) Citation

JD, Bernstock, et al. "A Novel in Situ Multiplex Immunofluorescence Panel for the Assessment of Tumor Immunopathology and Response to Virotherapy in Pediatric Glioblastoma Reveals a Role for Checkpoint Protein Inhibition." Oncoimmunology 8, no. 12 (2019): e1678921. https://doi.org/10.1080/2162402X.2019.1678921.

MLA (9th ed.) Citation

JD, Bernstock, et al. "A Novel in Situ Multiplex Immunofluorescence Panel for the Assessment of Tumor Immunopathology and Response to Virotherapy in Pediatric Glioblastoma Reveals a Role for Checkpoint Protein Inhibition." Oncoimmunology, vol. 8, no. 12, 2019, p. e1678921, https://doi.org/10.1080/2162402X.2019.1678921.